Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Insights: "Emerging Data and Ongoing Trials With Zanzalintinib, a Novel Multitargeted TKI in CRC"
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Anwaar Saeed
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Anwaar Saeed
Login to view comments.
Click here to Login